FUJIFILM VisualSonics Inc. has received a CE mark for the Vevo MD, the world’s first ultra high frequency (UHF) clinical ultrasound system.

“As the leader in ultra high frequency imaging systems, FUJIFILM VisualSonics advances the field of ultrasound with the launch of the Vevo MD,” said Masayuki Higuchi, president/CEO of FUJIFILM SonoSite Inc. “We are proud to be the first to bring to market this innovation that is sure to have high impact on the medical imaging community while expanding the product portfolio of FUJIFILM SonoSite.”

The Vevo MD operates at much higher frequencies than any conventional ultrasound system currently available, according to the company. Along with the Vevo MD system, FUJIFILM VisualSonics also introduces the UHF Series of transducers. This patented transducer technology is capable of operating in a range of frequencies up to 70 MHz, a tremendous increase in resolution compared to conventional ultrasound systems.

“The Vevo MD allows medical professionals to see what they have never seen before—unparalleled image resolution down to 30 micrometers. This is less than half the size of a grain of sand,” said Renaud Maloberti, vice president/general manager of FUJIFILM VisualSonics. “Imagine the great potential this technology has across unexplored applications to visualize the smallest, highly detailed anatomy in a way that has never been done before.”

“We believe this technology has a role to play in a range of clinical application areas from neonatology, vascular, musculoskeletal, dermatology, or other small parts that are within the first 3 cm of the body,” said Andrew Needles, director of marketing at FUJIFILM VisualSonics. “We also know that there are new and interesting areas to be discovered. The Vevo MD gives us and our users the opportunity to make those discoveries together.”

The Vevo MD is now commercially available with CE mark in the majority of European Union countries.

FUJIFILM VisualSonics Inc. is a developer and provider of real time, in vivo, ultra high frequency ultrasound and photoacoustic imaging systems. With headquarters in Toronto, Canada, and offices around the world, FUJIFILM VisualSonics provides imaging technologies for the advancement of preclinical research in cardiovascular, oncology, neurobiology and developmental biology areas. FUJIFILM VisualSonics is a subsidiary of FUJIFILM SonoSite Inc. and a part of FUJIFILM Holdings Corporation.

FUJIFILM SonoSite Inc. develops bedside and point-of-care ultrasound as well as ultra high-frequency micro-ultrasound technology. The company is headquartered near Seattle, Wash.

FUJIFILM Holdings Corporation of Tokyo, Japan, develops products for a broad spectrum of industries, including healthcare, graphic systems, highly functional materials, optical devices such as broadcast and cinema lenses; digital imaging; and document products. In the year ended March 31, 2015, the company had global revenues of $20.8 billion, at an exchange rate of 120 yen to the dollar. 

Watch the video below to learn more about the FUJIFILM VisualSonics’ Vevo MD: